IL17A and psoriasis: Additionally, evidence exhibited that ferroptosis inhibitors can block inflammatory responses in psoriasis with the reduced production of cytokines including TNF-α, IL-6, IL-1α, IL-1β, IL-17, IL-22, and IL-23 (35).